Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441081 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
GEP testing adds value for women initially unsure about chemotherapy treatment with a decrease in decisional conflict. However, for women who are confident about their treatment decisions, GEP testing may not add value. Decisions to request GEP testing should be personalised based on patient preferences.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Karen V. MacDonald, Yvonne Bombard, Ken Deal, Maureen Trudeau, Natasha Leighl, Deborah A. Marshall,